148 related articles for article (PubMed ID: 21593753)
1. Adverse drug reactions in utero: perspectives on teratogens and strategies for the future.
Mitchell AA
Clin Pharmacol Ther; 2011 Jun; 89(6):781-3. PubMed ID: 21593753
[TBL] [Abstract][Full Text] [Related]
2. 45 years later...where do we stand?
Benegbi M
Can J Clin Pharmacol; 2007; 14(1):e37-9. PubMed ID: 17213509
[No Abstract] [Full Text] [Related]
3. Risk minimization practices for pregnancy prevention: understanding risk, selecting tools.
Uhl K; Trontell A; Kennedy D
Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):337-48. PubMed ID: 16953517
[TBL] [Abstract][Full Text] [Related]
4. Drugs in pregnancy.
Koren G; Pastuszak A; Ito S
N Engl J Med; 1998 Apr; 338(16):1128-37. PubMed ID: 9545362
[No Abstract] [Full Text] [Related]
5. Linking a pharmaceutical claims database with a birth defects registry to investigate birth defect rates of suspected teratogens.
Colvin L; Slack-Smith L; Stanley FJ; Bower C
Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1137-50. PubMed ID: 20602344
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcome after in utero exposure to colchicine.
Diav-Citrin O; Shechtman S; Schwartz V; Avgil-Tsadok M; Finkel-Pekarsky V; Wajnberg R; Arnon J; Berkovitch M; Ornoy A
Am J Obstet Gynecol; 2010 Aug; 203(2):144.e1-6. PubMed ID: 20579964
[TBL] [Abstract][Full Text] [Related]
7. Drug exposure in pregnancy and heart defects.
Matok I; Pupco A; Koren G
J Cardiovasc Pharmacol; 2011 Jul; 58(1):20-4. PubMed ID: 21499119
[TBL] [Abstract][Full Text] [Related]
8. New ways to detect adverse drug reactions in pediatrics.
Rieder M
Pediatr Clin North Am; 2012 Oct; 59(5):1071-92. PubMed ID: 23036245
[TBL] [Abstract][Full Text] [Related]
9. Adverse environmental exposures in pregnancy: teratology in adolescent medicine practice.
Seaver LH
Adolesc Med; 2002 Jun; 13(2):269-91, vi. PubMed ID: 11986036
[TBL] [Abstract][Full Text] [Related]
10. Exposing fetal drug exposure.
DeVane L; Goetzl LM; Ramamoorthy S
Clin Pharmacol Ther; 2011 Jun; 89(6):786-8. PubMed ID: 21593755
[TBL] [Abstract][Full Text] [Related]
11. The estimation of human teratogenic/fetotoxic risk of exposures to drugs on the basis of Hungarian experience: a critical evaluation of clinical and epidemiological models of human teratology.
Czeizel AE
Expert Opin Drug Saf; 2009 May; 8(3):283-303. PubMed ID: 19505262
[TBL] [Abstract][Full Text] [Related]
12. Human teratogens update 2011: can we ensure safety during pregnancy?
Rasmussen SA
Birth Defects Res A Clin Mol Teratol; 2012 Mar; 94(3):123-8. PubMed ID: 22328359
[TBL] [Abstract][Full Text] [Related]
13. International monitoring for adverse drug reactions of long latency.
Fletcher AP; Griffin JP
Adverse Drug React Toxicol Rev; 1991; 10(4):209-30. PubMed ID: 1793771
[No Abstract] [Full Text] [Related]
14. Research challenges for drug-induced birth defects.
Mitchell AA
Clin Pharmacol Ther; 2016 Jul; 100(1):26-8. PubMed ID: 27037730
[TBL] [Abstract][Full Text] [Related]
15. Prescription of medications during pregnancy: accidents, compromises, and uncertainties.
Hernández-Díaz S
Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):613-7. PubMed ID: 16941520
[No Abstract] [Full Text] [Related]
16. Interferon beta babies.
Waubant E; Sadovnick AD
Neurology; 2005 Sep; 65(6):788-9. PubMed ID: 16186513
[No Abstract] [Full Text] [Related]
17. FDA pregnancy risk categories and the CPS: do they help or are they a hindrance?
Law R; Bozzo P; Koren G; Einarson A
Can Fam Physician; 2010 Mar; 56(3):239-41. PubMed ID: 20228306
[TBL] [Abstract][Full Text] [Related]
18. Human teratogens: update 2010.
Holmes LB
Birth Defects Res A Clin Mol Teratol; 2011 Jan; 91(1):1-7. PubMed ID: 21254353
[TBL] [Abstract][Full Text] [Related]
19. Adverse drug reactions in hospitalized patients: A critique of a meta-analysis.
Kvasz M; Allen IE; Gordon MJ; Ro EY; Estok R; Olkin I; Ross SD
MedGenMed; 2000 Apr; 2(2):E3. PubMed ID: 11104449
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug reactions: moving from chance to science.
Haller C; James LP
Clin Pharmacol Ther; 2011 Jun; 89(6):761-4. PubMed ID: 21593747
[No Abstract] [Full Text] [Related]
[Next] [New Search]
